What is a HIDA (Hepatobiliary Iminodiacetic Acid) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a HIDA Scan?

A HIDA (Hepatobiliary Iminodiacetic Acid) scan is a nuclear medicine imaging study that uses a radioactive tracer (technetium-99m labeled iminodiacetic acid derivative) to evaluate the function of the liver, gallbladder, bile ducts, and cystic duct by tracking bile flow through the hepatobiliary system. 1, 2

How the Test Works

Mechanism of Action:

  • The radiotracer is injected intravenously and rapidly extracted by hepatocytes in the liver, similar to how bilirubin is processed 1, 2
  • In normal subjects, the tracer is cleared from blood circulation within 10 minutes (83% cleared), with only 17% remaining in the bloodstream 1
  • The liver visualizes by 5 minutes, reaches maximum uptake at 11 minutes, and the hepatic duct and gallbladder appear by 10-15 minutes 1
  • Intestinal activity is typically seen by 30-60 minutes in patients with normal hepatobiliary function 1
  • Only 1% of the injected dose is excreted in urine during the first 3 hours in normal patients 1

Primary Clinical Indications

Acute Cholecystitis Diagnosis:

  • HIDA scan has the highest sensitivity (84.2-89.3%) and specificity (66.8-79%) for diagnosing acute cholecystitis compared to all other imaging modalities 3, 4
  • The diagnosis is made by demonstrating non-filling of the gallbladder due to cystic duct obstruction 2, 5
  • HIDA sensitivity (84.2%) significantly exceeds ultrasound (67.3%) and CT (59.8%) for acute cholecystitis (p=0.017) 3
  • An absent gallbladder image with a normal hepatogram strongly supports acute cholecystitis, while gallbladder visualization excludes this diagnosis 5

Functional Gallbladder Disorder (Biliary Dyskinesia):

  • CCK-augmented HIDA scanning measures gallbladder ejection fraction (GBEF) to diagnose chronic acalculous cholecystitis and functional gallbladder disorder 4, 6
  • The standardized protocol uses 0.02 μg/kg sincalide infused over 60 minutes, with abnormal GBEF defined as <38% 4, 6
  • CCK-augmented HIDA is NOT indicated for acute calculous cholecystitis where cystic duct obstruction is already present 4

Other Diagnostic Applications:

  • Detection of high-grade biliary obstruction before ductal dilatation occurs (shows persistent hepatogram without biliary clearance) 2
  • Diagnosis of partial biliary obstruction from stones, strictures, or sphincter of Oddi dysfunction 2
  • Confirmation of biliary leakage post-cholecystectomy or after hepatic transplantation 2
  • Evaluation of congenital gallbladder and biliary duct anomalies 7

Patient Preparation Requirements

Critical Pre-Test Restrictions:

  • Patients must fast for 4-6 hours (optimally overnight) to ensure adequate gallbladder filling with bile 4, 6
  • Anticholinergic drugs must be withheld for at least 48 hours because they impair gallbladder contraction and cause false-positive results 4, 6
  • Opiates must be withheld for at least 48 hours before testing 4, 6
  • Other medications to avoid within 24 hours include nifedipine, indomethacin, octreotide, theophylline, benzodiazepines, phentolamine, isoproterenol, and progesterone 4
  • Nicotine and alcohol should also be avoided prior to testing 4

Clinical Positioning in Diagnostic Algorithm

When to Order HIDA:

  • Ultrasound remains the first-line imaging modality for suspected gallstone cholecystitis due to lower cost, portability, and lack of radiation 4, 6
  • Consider HIDA scan when ultrasound findings are equivocal but clinical suspicion for acute cholecystitis remains high 4, 6
  • HIDA is recommended after other diagnostic possibilities for right upper quadrant pain have been ruled out 4

Practical Limitations:

  • HIDA scan utilization in clinical practice is limited due to required resources, time, and availability 3, 6
  • This resource intensity explains why HIDA is positioned as second or third-line imaging after ultrasound and potentially CT 6

Special Considerations in Jaundiced Patients

Impact of Elevated Bilirubin:

  • Elevated serum bilirubin levels increase renal excretion of the radiotracer 1
  • In patients with mean bilirubin of 9.8 mg/dL, urinary excretion increases to 3% in the first 3 hours and 14.9% during 3-24 hours (compared to 1% in normal patients) 1
  • Blood retention at 10 minutes may be twice as high or more in jaundiced patients 1
  • Hepatobiliary transit is delayed, visualization times increase, and image quality frequently diminishes 1

Common Pitfalls to Avoid

  • Do not use rapid CCK infusion (<30 minutes), as this causes non-specific abdominal symptoms that confound interpretation 6
  • Failure to withhold anticholinergics or opiates will result in spuriously decreased GBEF and false-positive results 4, 6
  • The test should be performed on an outpatient basis when possible, not during acute illness, particularly for functional gallbladder assessment 4
  • In chronic gallbladder disease without acute inflammation, HIDA offers no advantage over oral cholecystogram 5

References

Research

Nuclear medicine hepatobiliary imaging.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach for Gallstone Cholecystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

HIDA scanning in gall-bladder disease.

The British journal of radiology, 1980

Guideline

HIDA Scan in Diagnosing Gallbladder Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.